Immune, Solvents & Others
Immune modulators, clinical laboratory research solvents, and secondary structures formulated for complex study models.
Compounds in this category
-
Tuftsin
Naturally occurring tetrapeptide phagocytosis-stimulating agent evaluated for immune defense.
C21H40N6O6 · 472.6 g/mol · 99.85% assay
-
Thymosin Alpha-1 (Immune)
Immunomodulating Thymosin Alpha-1 segment evaluated for systemic immune response optimization.
C129H215N33O55 · 3108.3 g/mol · 99.60% assay
-
LL-37 (Immune Grade)
Cathelicidin immune segment researched for biofilm disruption and cellular pathogens defense.
C205H340N60O53 · 4493.3 g/mol · 99.15% assay
-
KPV (Dermal & Immune)
Purified KPV tripeptide tailored for contact dermatitis and systemic cytokine balancing studies.
C16H30N4O4 · 342.4 g/mol · 99.85% assay
-
Thymopentin (Immune)
Thymopentin (TP-5) segment targeting lymphocyte maturation and cellular immune validation.
C30H49N9O9 · 679.8 g/mol · 99.65% assay
-
Splenopentin (SP-5)
Splenic peptide analog evaluated for T-cell subset balance and antibody optimization.
C31H51N9O9 · 693.79 g/mol · 99.55% assay
-
VIP Peptide
Vasoactive Intestinal Peptide studied for lung mucosal barrier preservation and vasodilation.
C147H237N43O43S · 3326.8 g/mol · 99.42% assay
-
PACAP-38
Pituitary adenylate cyclase-activating peptide investigated for immune and cognitive recovery.
C203H331N63O53S · 4534.3 g/mol · 99.30% assay
-
Substance P Segment
Neuropeptide regulating cellular immune inflammatory responses and pain signaling.
C63H98N18O13S · 1347.6 g/mol · 99.62% assay
-
Buserelin
GnRH receptor agonist used as clinical reference compound for endocrine research.
C60H86N16O13 · 1239.4 g/mol · 99.70% assay
-
Leuprolide
GnRH agonist evaluated for oncology models and endocrine signaling pathways.
C59H84N16O12 · 1209.4 g/mol · 99.80% assay
-
Histrelin
Highly potent GnRH agonist evaluated for central endocrine regulation studies.
C66H83N17O12 · 1323.5 g/mol · 99.72% assay
-
Goserelin
Synthetic decapeptide GnRH agonist investigated for hormone therapy models.
C59H84N18O14 · 1269.4 g/mol · 99.65% assay
-
Nafarelin
Naphthylalanine GnRH agonist studied for severe hormone dysregulation models.
C66H83N17O13 · 1322.5 g/mol · 99.78% assay
-
Cetrorelix
Synthetic decapeptide GnRH antagonist investigated for immediate hormone suppression.
C70H92ClN17O14 · 1431.0 g/mol · 99.82% assay
-
Ganirelix
Highly selective GnRH antagonist used for immediate endocrine axis control.
C80H113ClN18O13 · 1570.4 g/mol · 99.85% assay
-
Degarelix
Third-generation GnRH antagonist evaluated for immediate androgen suppression models.
C82H103ClN18O16 · 1632.3 g/mol · 99.70% assay
-
Abarelix
Synthetic peptide GnRH antagonist investigated for rapid endocrine axis down-regulation.
C72H95ClN14O14 · 1416.1 g/mol · 99.55% assay
-
Octreotide
Synthetic somatostatin octapeptide analogue researched for endocrine and gut barrier validation.
C49H66N10O10S2 · 1019.2 g/mol · 99.90% assay
-
Lanreotide
Long-acting somatostatin receptor agonist analyzed for cellular proliferation suppression.
C54H69N11O10S2 · 1096.3 g/mol · 99.82% assay
-
Pasireotide
Multi-receptor somatostatin analogue studied for complex pituitary tumor research.
C58H66N10O9 · 1047.2 g/mol · 99.78% assay
-
Teriparatide (PTH 1-34)
Recombinant human parathyroid hormone fragment analyzed for bone density restoration.
C181H291N55O51S2 · 4117.8 g/mol · 99.60% assay
-
Abaloparatide
Parathyroid hormone-related peptide analogue investigated for rapid skeletal structure restoration.
C174H300N56O49S · 3961.0 g/mol · 99.65% assay
-
Romosozumab Loop
Targeted sclerostin inhibitor fragment analyzed for systemic osteoblast pathway stimulation.
Complex antibody fragment loop mapping · 149 kDa (Full) · 99.10% assay
-
Bacteriostatic Water
Reconstitution solvent containing benzyl alcohol preservative, researched for multi-dose peptide stability.
H2O with 0.9% Benzyl Alcohol · 18.02 g/mol · 99.99% assay